Yayın: Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study)
| dc.contributor.author | Bilici, Ahmet | |
| dc.contributor.author | Ölmez, Ömer Fatih | |
| dc.contributor.author | Sezer, Ahmet | |
| dc.contributor.author | Öksuzoglu, Berna | |
| dc.contributor.author | Kaplan, Muhammet Ali | |
| dc.contributor.author | Karadurmuş, Nuri | |
| dc.contributor.author | Çubukcu, Erdem | |
| dc.contributor.author | Sendur, Mehmet A. N. | |
| dc.contributor.author | Aksoy, Sercan | |
| dc.contributor.author | Erdem, Dilek | |
| dc.contributor.author | Basaran, Gül | |
| dc.contributor.author | Çakar, Burcu | |
| dc.contributor.author | Şeker, Mesut | |
| dc.contributor.author | Arslan, Çağatay | |
| dc.contributor.author | Göksu, Sema Sezgin | |
| dc.contributor.author | Cicin, İrfan | |
| dc.contributor.author | Gumus, Mahmut | |
| dc.contributor.author | Selçukbiricik, Fatih | |
| dc.contributor.author | Harputluoğlu, Hakan | |
| dc.contributor.author | Helvacı, Kaan | |
| dc.contributor.buuauthor | ÇUBUKÇU, ERDEM | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.researcherid | ETP-1691-2022 | |
| dc.date.accessioned | 2024-11-20T11:44:22Z | |
| dc.date.available | 2024-11-20T11:44:22Z | |
| dc.date.issued | 2022-06-01 | |
| dc.description | Bu çalışma, 03-07, Haziran 2022 tarihlerinde düzenlenen Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) Kongresi‘nde bildiri olarak sunulmuştur. | |
| dc.description.sponsorship | Roche Holding | |
| dc.identifier.issn | 0732-183X | |
| dc.identifier.issue | 16, Supplement S | |
| dc.identifier.uri | https://hdl.handle.net/11452/48222 | |
| dc.identifier.volume | 40 | |
| dc.identifier.wos | 000863680302513 | |
| dc.indexed.wos | WOS.SCI | |
| dc.indexed.wos | WOS.ISTP | |
| dc.language.iso | en | |
| dc.publisher | Lippincott Williams & Wilkins | |
| dc.relation.journal | Journal of Clinical Oncology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Oncology | |
| dc.title | Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study) | |
| dc.type | Other | |
| dc.type.subtype | Meeting Abstract | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi | |
| local.indexed.at | WOS | |
| relation.isAuthorOfPublication | f971677f-09c5-4463-bf01-3c6341fbe5f7 | |
| relation.isAuthorOfPublication.latestForDiscovery | f971677f-09c5-4463-bf01-3c6341fbe5f7 |
